Expression of the kynurenine pathway enzymes in human microglia and macrophages
- PMID: 15206722
- DOI: 10.1007/978-1-4615-0135-0_12
Expression of the kynurenine pathway enzymes in human microglia and macrophages
Abstract
There is good evidence that the kynurenine pathway (KP) and one of its products, quinolinic acid (QUIN) play a role in the pathogenesis of neurological diseases. Monocytic cells are known to be the major producers of QUIN. However, macrophages have the ability to produce approximately 20 to 30-fold more QUIN than microglia. The molecular origin of this difference has not been clarified yet. Using unstimulated and IFN-gamma-stimulated cultures of human fcetal microglia and adult macrophages, we assayed mRNA expression of 8 key enzymes of the KP using RT-PCR and QUIN production using GC-MS. We found that after stimulation with IFN-gamma microglia produced de novo 20-fold less QUIN than macrophages. This quantitative difference in the ability to produce QUIN appears to be associated with a lower expression of 3 important enzymes of the KP in microglia: indoleamine 2,3-dioxygenase (IDO), kynureninase (KYNase) and kynurenine hydroxylase (KYN(OH)ase). These results suggest that activated infiltrating macrophages are the most potent QUIN producers during brain inflammatory diseases with playing a lesser role.
Similar articles
-
Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons.Glia. 2005 Jan 1;49(1):15-23. doi: 10.1002/glia.20090. Glia. 2005. PMID: 15390107
-
A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.Brain. 1993 Dec;116 ( Pt 6):1425-50. doi: 10.1093/brain/116.6.1425. Brain. 1993. PMID: 8293279
-
Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells.J Neurochem. 1996 Mar;66(3):996-1004. doi: 10.1046/j.1471-4159.1996.66030996.x. J Neurochem. 1996. PMID: 8769859
-
Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis.Neurodegener Dis. 2005;2(3-4):166-76. doi: 10.1159/000089622. Neurodegener Dis. 2005. PMID: 16909022 Review.
-
Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease.Redox Rep. 2002;7(4):199-206. doi: 10.1179/135100002125000550. Redox Rep. 2002. PMID: 12396664 Review.
Cited by
-
Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise.Front Neuroendocrinol. 2012 Aug;33(3):315-27. doi: 10.1016/j.yfrne.2012.09.003. Epub 2012 Sep 21. Front Neuroendocrinol. 2012. PMID: 23000204 Free PMC article. Review.
-
Immunosenescence and inflamm-ageing in COVID-19.Ageing Res Rev. 2023 Feb;84:101818. doi: 10.1016/j.arr.2022.101818. Epub 2022 Dec 11. Ageing Res Rev. 2023. PMID: 36516928 Free PMC article. Review.
-
Stress and Kynurenine-Inflammation Pathway in Major Depressive Disorder.Adv Exp Med Biol. 2023;1411:163-190. doi: 10.1007/978-981-19-7376-5_8. Adv Exp Med Biol. 2023. PMID: 36949310
-
Understanding the roles of the kynurenine pathway in multiple sclerosis progression.Int J Tryptophan Res. 2010;3:157-67. doi: 10.4137/ijtr.s4294. Epub 2010 Aug 25. Int J Tryptophan Res. 2010. PMID: 22084596 Free PMC article.
-
Involvement of the kynurenine pathway in breast cancer: updates on clinical research and trials.Br J Cancer. 2023 Aug;129(2):185-203. doi: 10.1038/s41416-023-02245-7. Epub 2023 Apr 11. Br J Cancer. 2023. PMID: 37041200 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
